The 20 Best Choroid Plexus Carcinoma Doctors Near Me in Poughkeepsie, NY

Sherif Khedr is an Ophthalmologist practicing medicine in Cooperstown, New York. Dr. Khedr is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.

Laura Kilty is an Ophthalmologist practicing medicine in Cooperstown, New York. Dr. Kilty is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Strabismus, Glaucoma, Blepharitis, and Esotropia.

Dr. Paul T. Finger has collected or discovered the latest and most advanced medical technologies for the diagnosis and treatment of ocular tumors and eye cancer.With great respect for collaboration, he works closely with you, your referring doctor and his associated specialists to provide the most excellent care possible.The New York Eye Cancer Center was designed to be a responsive and caring environment, we strive to be your and your doctor's first choice for eye cancer care.Dr. Finger is the Director of Ocular Tumor Services at the Manhattan Eye, Ear and Throat Hospital and teaches residents from the New York University School of Medicine.A world-recognized expert in radiation and surgical techniques to conserve the eye and vision; Dr. Finger has pioneered the use of palladium-103 plaque radiation for choroidal melanoma, 3D and high-frequency ultrasound to image intraocular tumors, and created this world-renowned web site. Dr. Finger publishes in the major clinical journals and lectures frequently at local, national and international meetings. He graduated from Tulane Medical School, the Manhattan Eye, Ear and Throat Hospital, and then completed specialty training in treatment of ocular tumors and orbital diseases.Dr. Finger is certified by the American Board of Ophthalmology and is a Fellow of both the American College of Surgeons and the American Academy of Ophthalmology and sees patients from all over the world.Dr Finger was a principal investigator for The Collaborative Ocular Melanoma Study. He Chaired the Ophthalmic Oncology Task Force that wrote the 2014 consensus guidelines for plaque radiationt therapy of choroidal melanoma and retinoblastoma for The American Brachytherapy Society. Dr. Finger was the clinical director for the Plaque Radiation Therapy (Task Group 129) of the American Association for Physicists in Medicine (AAPM). Dr. Finger is Chair of the Ophthalmic Oncology Task Group of The American Joint Committee on Cancer (AJCC) - International Union Against Cancer (UICC). The AJCC-UICC has created a universal language (TNM-classification) commonly used around the world to describe eye cancer.Dr. Finger has a particular interest in melanoma of the choroid, ciliary body and iris. He has written extensively about new ways to detect and treat retinoblastoma, conjunctival melanoma, squamous carcinoma, metastatic cancer to the eye and orbital tumors.Dr. Finger has assembled a team to care for patients with eye tumors. By picking the best doctors from several institutions, his team includes the top radiation, medical and pediatric oncologists from several institutions in New York City.Dr. Finger has spent his career inventing and improving new methods of diagnosis and treatment for eye cancer:. Dr. Finger is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, Iridectomy, and Vitrectomy.

Howard Charles is an Ophthalmologist practicing medicine in Mount Kisco, New York. Dr. Charles is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Diabetic Retinopathy. Dr. Charles is board certified in American Board Of Ophthalmology.

Craig Richter is an Ophthalmologist practicing medicine in Huntington, New York. Dr. Richter is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Chalazion, Subconjunctival Hemorrhage, and Cataract.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Usher Syndrome, and Usher Syndrome Type 2A.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma.Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008.Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network. Dr. Marr is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy. Dr. Marr is board certified in Ophthalmology. Dr. Marr is currently accepting new patients.

Christopher Barker is a Radiation Oncologist practicing medicine in New York, New York. Dr. Barker is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Squamous Cell Skin Carcinoma, Melanoma of the Eye, and Liver Embolization. Dr. Barker is currently accepting new patients.

David Abramson is an Oncologist practicing medicine in New York, New York. Dr. Abramson is rated as a Distinguished provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation. Dr. Abramson is currently accepting new patients.

George Tung is an Ophthalmologist practicing medicine in Bellmore, New York. Dr. Tung is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Subconjunctival Hemorrhage, Dry Eye Syndrome, Eyelid Bump, and Chalazion. Dr. Tung is board certified in American Board Of Ophthalmology.

Jonathan Wesson is an Ophthalmologist practicing medicine in Glen Cove, New York. Dr. Wesson is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Blepharitis, and Subconjunctival Hemorrhage. Dr. Wesson is board certified in American Board Of Ophthalmology.

Samuel Baharestani is an Ophthalmologist practicing medicine in Smithtown, New York. Dr. Baharestani is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Chalazion, Eyelid Bump, Ptosis, and Eyelid Drooping. Dr. Baharestani is board certified in American Board Of Ophthalmology.

Aspasia Draga is an Ophthalmologist practicing medicine in Bayside, New York. Dr. Draga is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Choroid Plexus Carcinoma, Late-Onset Retinal Degeneration, Cataract, and Age-Related Macular Degeneration (ARMD). Dr. Draga is board certified in American Board Of Ophthalmology.

Howard Lane is an Ophthalmologist practicing medicine in New Hyde Park, New York. Dr. Lane is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Chalazion, Eyelid Bump, Conjunctivitis (Pink Eye), and Meibomianitis. Dr. Lane is board certified in American Board Of Ophthalmology.

Robert Rothman is an Ophthalmologist practicing medicine in Bethpage, New York. Dr. Rothman is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, and Cataract. Dr. Rothman is board certified in American Board Of Ophthalmology.

Jonathan Jonisch is an Ophthalmologist practicing medicine in Great Neck, New York. Dr. Jonisch is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Vein Occlusion. Dr. Jonisch is board certified in American Board Of Ophthalmology.

Jeffrey Shakin is an Ophthalmologist practicing medicine in Great Neck, New York. Dr. Shakin is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Retinal Vein Occlusion. Dr. Shakin is board certified in American Board Of Ophthalmology.

Irene Draga is an Ophthalmologist practicing medicine in Bayside, New York. Dr. Draga is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Glaucoma, and Hyphema. Dr. Draga is board certified in American Board Of Ophthalmology.

Eric Shakin is an Ophthalmologist practicing medicine in Westbury, New York. Dr. Shakin is rated as an Advanced provider by MediFind in the treatment of Choroid Plexus Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Diabetic Retinopathy, and Vitrectomy. Dr. Shakin is board certified in American Board Of Ophthalmology.